Take the advice of industry experts and AOs—the key to acing the MDSAP audit is to prepare, prepare, prepare.
The MDSAP audit process is intense in that it is
designed to provide thorough coverage of QMS and multiple jurisdictions
regulations. Remember, your organization already maintains a level of
compliance in all countries they sell devices. MDSAP simply rolls all these
regulatory requirements into an efficient process. Here are a few tips to keep
in mind when preparing for the MDSAP audit.
1. Look closely at the MDSAP Audit Model to determine exactly what the Auditing Organization (AO) will need. The MDSAP Audit Model is the AOs guide. Everything needed for the audit is clearly laid out in this comprehensive guide. Each of the 90 questions the AO will ask is contained in this guide. And, each question is cross-referenced to relevant sections of ISO 13485:2016 and other specific requirements of medical device regulatory authorities participating in the MDSAP program.
2. Use the MDSAP Companion Document to create a gap analysis and perform an internal audit. It is universally agreed by AOs and manufacturers that have been through the MDSAP audit process that the best way to get ready for an MDSAP audit is to use the MDSAP Companion Document as a guideline. The Companion Document further clarifies the Audit Model and provides guidance to the auditors, making this a very handy supplement for manufacturers. MDSAP is very structured, and understanding the specific information that auditors will be focusing on and in which order eliminates any guesswork by the manufacturer.
3. All documents need to be
organized and available.
The audit is timed. Therefore, the vast volume of documents required need to be
organized and quickly accessible—this is critical for a successful audit. The
AO will not be able to come back and revisit areas in which documents are not
readily available.
4. Organizations must prove control over their suppliers. The way in which you demonstrate control over your suppliers needs to justified, and these details need to be incorporated into procedures and programs. A manufacture cannot simply say their supplier is ISO or MDSAP certified. The AO wants to know how your organization ensures that the supplier is compliant. Here’s why a global medical device manufacturer should consider the MDSAP.
6. Be clear on what is done where. This aspect is especially important for multi-site manufactures.
Clearly list the scope of activity at each site and which products are covered
by operations. Make sure to define multi-site manufacturing in Stage 1 so the
AO can calculate the appropriate time-frame for Stage 2.
7. Employees must be proven
competent. Providing objective
evidence that employees are competent, not just trained, in regulatory
requirements of all pertinent jurisdictions is mandatory. Objective
evidence could include testing after training and job function checks to assure
competency is practiced—not just learned.
8. Consider the Auditors Perspective. Brian Ludovico, Executive Director at NSF International, suggest
organizations keep in mind the AOs perspectives when preparing for the MDSAP
Audit. He provided a number of additional tips in recent interviews: auditors
cannot read your mind, please justify your work, and regulatory and quality
need to be friends in your organization.
9. Learn From Past Mistakes. Marcelo Trevino,
Senior VP of Regulatory Affairs and Quality Systems at Applied Medical, provides
insights on how to avoid some of the most common mistakes with European
regulatory compliance.
If you are ready to bypass the hassle of multiple regulatory inspections and undergo a single, rigorous audit which satisfies the quality regulation of each jurisdiction, consider transitioning to MDSAP.
Fill out this form, or contact us at info@criterionedge.com, and we would be happy to answer any of your questions as well as book you an appointment to discuss your project needs during a time that works for you.
Are You Reg. Ready? Get your medical affairs team primed to manage new regulatory requirements
In this discussion, we provide an overview of how to plan and coordinate change within an organization to meet upcoming EU IVDR regulatory requirements. We will be highlighting key steps involved in helping medical affairs transition to a more rigorous regulatory environments, and how to evaluate talent gaps, team leadership composition, and process challenges of your product portfolio.
Driving Innovation to Success in the Market: Strategic Considerations
In this discussion, our panel of proven leaders discuss the key elements that support and propel the innovation process in the medical device, pharmaceutical, and IVD industries. We will be highlighting key areas of the process, important players in the pathway to the market, and how successful innovations spawn new innovations in new markets such as the digital health space, and more.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Tag Manager and Pardot's tracking features to collect information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!